Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
A Study for Treatment of Superficial Bladder Cancer Using OGX-427 (NCT00959868)Vancouver Coastal Health2009-07-01
Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy (NCT00942903)Atos Medical AB2009-07-01
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors (NCT00967577)Weill Medical College of Cornell University2009-07-01
Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes Mellitus (NCT00940173)Diatranz Otsuka Limited2009-07-01
DC Vaccine for Patients With Ductal Carcinoma In Situ (NCT02061332)Abramson Cancer Center at Penn Medicine2009-07-01
Gabapentin for the Treatment of Pruritus Caused by Burn Injuries in Children (NCT01092520)The Hospital for Sick Children2009-07-01
Study Evaluating Neratinib In Combination With Vinorelbine In Subjects With Advanced Or Metastatic Solid Tumors (NCT00958724)Puma Biotechnology, Inc.2009-07-01
DDI Study of Etravirine and GSK1265744 (NCT00920296)GlaxoSmithKline2009-07-01
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE) (NCT00960362)Argos Therapeutics2009-07-01
Dose Escalation Study to Assess the Safety and Tolerability of Genz-644282 in Patients With Solid Tumors (NCT00942799)Genzyme, a Sanofi Company2009-07-01
T-cells or EBV Specific CTLs, Advanced B-Cell NHL and CLL (NCT00709033)Baylor College of Medicine2009-07-01
Pharmacokinetic Interaction Study Between Eslicarbazepine Acetate and Carbamazepine (NCT02284854)Bial - Portela C S.A.2009-07-01
Pharmacokinetic Study Comparing Aspirin and Aspirin Granules (NCT01072604)Bayer2009-07-01
Single Dose of BI 1744 CL in Patients With Mild and Moderate Hepatic Impairment Compared to Subjects With Normal Hepatic Function (NCT02171832)Boehringer Ingelheim2009-07-01
Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome (NCT00884715)Endo USA Inc., a Keenova Therapeutics Company2009-07-01
A Pharmacokinetic And QT Study Of CP-751,871 In Healthy Subjects (NCT00926263)Pfizer2009-07-01
Relative Drug Exposures Of Two Formulations of PF-02341066 (NCT00939731)Pfizer2009-07-01
Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue (NCT00855088)University of North Carolina, Chapel Hill2009-07-01
A Pharmacokinetics, Pharmacodynamics and Safety Study of Rabeprazole in New Born Infants With Gastroesophageal Reflux Disease (GERD) (NCT00855361)Janssen Research & Development, LLC2009-07-01
RAD001 in Combination With CP-751,871 in Patients Wtih Advanced Sarcomas and Other Malignant Neoplasms (NCT00927966)Suzanne George, MD2009-07-01
A Pilot Study to Evaluate the Efficacy of Ariva® Silver Wintergreen, a Smoking Aversive Lozenge (NCT01336816)Star Scientific, Inc2009-07-01
Vorinostat in Treating Women With Ductal Carcinoma in Situ of the Breast (NCT00788112)University of California, San Francisco2009-07-01
Hepatic Arterial Infusion Oxaliplatin + 5FU, Leucovorin, and Bevacizumab +/- Cetuximab (NCT00941499)M.D. Anderson Cancer Center2009-07-01
AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects (NCT00935025)AstraZeneca2009-07-01
Single Ascending Dose Study of Oral CPSI-2364 (Semapimod) (NCT00950105)Ferring Pharmaceuticals2009-07-01
Combination Therapy for the Treatment of Rosacea (NCT00945373)Ellen Marmur2009-07-01
A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers (NCT00931073)Pfizer2009-07-01
Induction Therapy With Cytarabine, High-Dose Mitoxantrone and Dasatinib for Patients With Philadelphia-Chromosome Positive (Ph+) Acute Lymphoblastic Leukemia (NCT00940524)Memorial Sloan Kettering Cancer Center2009-07-01
Study to Evaluate the Potential Pharmacokinetic Interaction and Pharmacodynamic Effects on Renal Parameters of Bumetanide (1mg) and Dapagliflozin (10 mg) When Co-administered in Healthy Subjects (NCT00930865)AstraZeneca2009-07-01
A Study Investigating the Influence of Hepatic Insufficiency on the Pharmacokinetics of Vaniprevir (MK-7009-005) (NCT01010906)Merck Sharp & Dohme LLC2009-07-01
Study Comparing Two Different Tablet Formulations Of Bosutinib (NCT00934674)Wyeth is now a wholly owned subsidiary of Pfizer2009-07-01
The Trauma- Formula-Driven Versus Lab-Guided Study (TRFL Study) (NCT00945542)Sunnybrook Health Sciences Centre2009-07-01
Cipro Inhaler for Cystic Fibrosis Children Ages 6-12 (NCT00910351)Bayer2009-07-01
Non-invasive Neurally Adjusted Ventilatory Assist in Healthy Volunteers (NCT00941044)Insel Gruppe AG, University Hospital Bern2009-07-01
A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers (NCT00991705)Boryung Pharmaceutical Co., Ltd2009-07-01
The Effect Of Fesoterodine On Pharmacokinetics And Pharmacodynamics Of Warfarin In Healthy Subjects (NCT00914667)Pfizer2009-07-01
GSK1349572 Proton Pump Inhibitor Drug Interaction and Supratherapeutic Dose Study (NCT00942136)GlaxoSmithKline2009-07-01
Comparing the Use of Vitamin c (Ascorbic Acid) in Eye Burn in Subconjunctival Injection to Topical or Oral Treatment. (NCT00734695)The Baruch Padeh Medical Center, Poriya2009-07-01
Study of MDX-1203 in Subjects With Advanced/Recurrent Clear Cell Renal Cell Carcinoma (ccRCC) or Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL) (NCT00944905)Bristol-Myers Squibb2009-07-01
Band Holiday Study (NCT00967122)NYU Langone Health2009-07-01
Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes Mellitus (NCT02224118)Janssen Pharmaceutical K.K.2009-07-01
Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00935792)Mayo Clinic2009-07-01
Effect of Zinc Supplementation on Serum Zinc Level in Nursing Home Elderly (NCT01599572)Tufts University2009-07-01
Dysphagia in Oculopharyngeal Muscular Dystrophy (OPMD)- Evaluation, Endoscopic Examination of Swallowing, Treatment and Long Term Follow up (NCT01167439)Hillel Yaffe Medical Center2009-07-01
Lipid Biomarker Study in Men With Dyslipidemia After Simvastatin Treatment (Study MK-0000-140)(COMPLETED) (NCT00935259)Merck Sharp & Dohme LLC2009-07-01
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus (NCT00946972)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2009-07-01
A Study in Healthy Young Men to Look at What Drives the Cardiovascular Effects After Dosing With Mirabegron. (NCT01284868)Astellas Pharma Inc2009-07-01
Hepatocyte Matrix Implant Study (NCT00935454)Baermed2009-07-01
A Study to Evaluate the Pharmacokinetics of Duloxetine in Chinese Han Healthy Subjects (NCT00933452)Shanghai Mental Health Center2009-07-01
De Novo Pilot Study, Lutonix Catheter in Conjunction With Bare Metal Stenting for Treatment of Coronary De Novo Lesions (NCT00934752)C. R. Bard2009-07-01
Therapeutic Autologous Lymphocytes, Aldesleukin, and Denileukin Diftitox in Treating Patients With Stage III-IV Melanoma (NCT00945269)Fred Hutchinson Cancer Center2009-07-01
Intravitreal Diclofenac Versus Avastin as Primary Treatment of Diffuse Diabetic Macular Edema (NCT00999791)Shahid Beheshti University of Medical Sciences2009-07-01
Safety of and Immune Response to DEN4 Vaccine Component Candidate for Dengue Virus (NCT00919178)National Institute of Allergy and Infectious Diseases (NIAID)2009-07-01
Study of Pretargeted Radioimmunotherapy of a Anti-CEA Bispecific Antibody and Lu177-labeled Peptide in Colorectal Cancer (NCT00860860)Radboud University Medical Center2009-07-01
Pharmacogenetic Factors and Side Effects of Metoclopramide and Diphenhydramine (NCT01289938)Matthias Schwab2009-07-01
Peanut Oral Immunotherapy and Anti-Immunoglobulin E (IgE) for Peanut Allergy (NCT00932282)University of North Carolina, Chapel Hill2009-07-01
Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery (NCT00891072)National Cancer Institute (NCI)2009-07-01
Lokomat Versus Strength Training in Chronic Incomplete Spinal Cord Injury (NCT01087918)University of Zurich2009-07-01
Open, Single Center, Three Periods, Fixed Sequence Design Study on the Effects of Clopidogrel Co-administration on the Pharmacokinetics of Neramexane (NCT00936026)Merz Pharmaceuticals GmbH2009-07-01
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients (NCT00940160)Novartis Pharmaceuticals2009-07-01
Safety and Efficacy of a Single Dose of a Polyphenol-enriched Brown Seaweed Powder in Human (NCT00936754)innoVactiv Inc.2009-07-01
Study to Investigate Safety, Tolerability and Pharmacokinetics of AZD2423 in Healthy Volunteers (NCT00940212)AstraZeneca2009-07-01
Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer (NCT00954525)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2009-07-01
Ph1 Study of Valortim and Doxycycline in Humans (NCT00964834)PharmAthene, Inc.2009-07-01
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BI 10773 in Type II Diabetes Patients With Different Degrees of Renal Impairment (NCT01907113)Boehringer Ingelheim2009-07-01
Curcumin in Preventing Colorectal Cancer in Patients Undergoing Colorectal Endoscopy or Colorectal Surgery (NCT00973869)University of Leicester2009-07-01
Safety and Immunogenicity of Rotavirus Vaccine (RotaTeq(R)) in Infants With Short Bowel Syndrome (NCT00767364)Children's Hospital of Michigan2009-07-01
Study of the Effect of Single Doses of MK2637 and Dextromethorphan on Cerebral Cortex Excitability (2637-008) (NCT00934466)Merck Sharp & Dohme LLC2009-07-01
Safety and Tolerability Study of Clemizole Hydrochloride to Treat Hepatitis C in Subjects Who Are Treatment-Naive (NCT00945880)Eiger BioPharmaceuticals2009-07-01
Safety Study of ABT-263 in Combination With Paclitaxel in Subjects With Solid Tumors (NCT00891605)AbbVie2009-07-01
A Study to Evaluate the Biological Activity of R1507 in Women With Operable Breast Cancer (NCT00882674)Hoffmann-La Roche2009-07-01
Safety, Pharmacokinetics and Pharmacodynamics Study of BMS-866949 in Healthy Subjects (NCT00949767)Bristol-Myers Squibb2009-07-01
Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy (NCT00933816)Kindai University2009-07-01
Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma (NCT00962507)City of Hope Medical Center2009-07-01
A First Time in Man, Study to Assess the Safety of AZD8329 After Single Ascending Oral Doses (NCT00935662)AstraZeneca2009-07-01
Safety and Tolerability of Repeat Doses of ACU-4429 in Healthy Subjects (NCT00942240)Kubota Vision Inc.2009-07-01
Antenatal Vitamin D3 Dose-finding and Safety Study (NCT00938600)Johns Hopkins Bloomberg School of Public Health2009-07-01
Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors (NCT00935545)NYU Langone Health2009-07-01
Whole Abdomen Radiation in Conjunction With Intraperitoneal Chemotherapy for the Treatment of Small Volume Recurrent Ovarian Carcinoma Limited to the Peritoneal Cavity (NCT00942838)University of Utah2009-07-01
Study to Investigate the Safety, Tolerability and Activity of AZD5069 When Given as a Single Dose to Healthy Male and/or Female Subjects (NCT00953888)AstraZeneca2009-07-01
Occipital Transcranial Direct Current Stimulation in Fibromyalgia (NCT00947622)University Hospital, Antwerp2009-07-01
Sirolimus as Therapeutic Approach to Uveitis (NCT00908466)Johns Hopkins University2009-07-01
Study of HBV-001 D1 in Healthy Adults (NCT00936429)Hawaii Biotech, Inc.2009-07-01
Assessment of Systemically Administered Torisel Delivery to Brain Tumors by Intratumoral Microdialysis (NCT00949026)Emory University2009-07-01
Sirolimus and Cetuximab in Advanced Malignancies (NCT00940381)M.D. Anderson Cancer Center2009-07-01
Pharmacokinetic Study of Oseltamivir and Intravenous Zanamivir in Healthy Adults (NCT00921726)National Institute of Allergy and Infectious Diseases (NIAID)2009-07-01
Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia (NCT01093573)Brenda Cooper, MD2009-07-01
A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers (NCT00951873)Novo Nordisk A/S2009-07-01
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers (NCT00926640)National Cancer Institute (NCI)2009-07-01
Whole Body Cooling Using Phase Changing Material (NCT01138176)Robertson, Nicola, M.D.2009-07-01
Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Aplastic Anemia (NCT01105273)Asan Medical Center2009-07-01
Autologous Adipose Derived MSCs Transplantation in Patient With Spinal Cord Injury. (NCT01274975)R-Bio2009-07-01
Effects of Intact and Hydrolyzed Pea Protein on Food Intake, Glycemic Response and Subjective Appetite (NCT01298154)University of Toronto2009-07-01
A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer (NCT00934856)Hoffmann-La Roche2009-07-01
A Study Evaluating the Bioequivalence of VIAject®7 Compared to VIAject®25 and Comparing the Pharmacokinetic and Pharmacodynamic Properties of VIAject®7 to Insulin Lispro in Subjects With Type 1 Diabetes Mellitus (NCT01235039)Biodel2009-07-01
Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer (NCT00952692)Michael Morse, MD2009-07-01
Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome (NCT01009502)Northwestern University2009-07-01
Phase I Study to Investigate Pharmacokinetics and Safety of BAY73-4506 in Asian (Japanese) Patients With Solid Tumors. (NCT00960258)Bayer2009-07-01
Trastuzumab and Trastuzumab-MCC-DM1 Administered Intravenously and GDC-0941 Administered Orally to Patients With HER2-Positive Metastatic Breast Cancer Who Have Progressed on Previous Trastuzumab-Based Therapy (NCT00928330)Genentech, Inc.2009-07-01
Effect of Antacids on the Pharmacokinetics of Raltegravir (NCT00944307)University of Colorado, Denver2009-07-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.